Pay in 4 interest-free payments of $6.15 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Items can be returned or exchanged within 30 days of delivery
If a change in the injection day is required, ensure a minimum interval of 48 hours since the previous dose
Tirzepatide is a once-weekly injectable medication approved by the FDA for the treatment of type 2 diabetes (marketed as Mounjaro) and chronic weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity (marketed as Zepbound)
In addition, patients with major depressive disorder may suffer from either increases or decreases in appetite and weight during a depressive episode (Milaneschi et al., 2019), which is associated with differences in energy metabolism (Simmons et al., 2018) and function of the reward circuit (Kroemer et al., 2022
